Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

"Green Oncology": the Italian medical oncologists' challenge to reduce the ecological impact of their clinical activity.

Bretti S, Porcile G, Romizi R, Palazzo S, Oliani C, Crispino S, Labianca R.

Tumori. 2014 May-Jun;100(3):e94-7. doi: 10.1700/1578.17246.

PMID:
25076260
2.

Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).

Banna GL, Di Maio M, Follador A, Collovà E, Menis J, Novello S, Bria E; ISA Co-Authors, Airoldi M, Amoroso D, Ardizzoia A, Aurilio G, Bajetta E, Ballardini P, Barbieri F, Barletta E, Balzelloni ML, Basso U, Bernardini I, Boni C, Bordin V, Bretti S, Bronte G, Brunetti C, Buti S, Capanna L, Colombo A, Condemi G, Cortinovis D, Dambrosio M, Di Fonzo C, Di Lucca G, Dima G, Falzetta A, Favaretto A, Ferraù F, Garetto L, Gebbia V, Genestreti G, Gentile AL, Giovanardi F, Labianca R, Lorusso V, Mantovani G, Martelli O, Massari F, Mazzoli M, Michetti G, Mordenti P, Mucciarini C, Munao S, Nacci A, Pogliani C, Procopio G, Riccardi F, Rizzato S, Rossi A, Rosti G, Russo P, Saladino T, Salesi N, Santangelo D, Sava T, Savarino A, Spinnato F, Tiseo M, Tomassi O, Tondulli L, Tonini G, Turano S, Valerio MR, Verderame F, Zanelli F, Zanon E.

Lung Cancer. 2011 Jul;73(1):78-88. doi: 10.1016/j.lungcan.2010.10.020. Epub 2010 Dec 8.

PMID:
21144614
3.

Radical resection of a giant, invasive and symptomatic malignant Solitary Fibrous Tumour (SFT) of the pleura.

Filosso PL, Asioli S, Ruffini E, Rovea P, Macri' L, Sapino A, Bretti S, Lyberis P, Oliaro A.

Lung Cancer. 2009 Apr;64(1):117-20. doi: 10.1016/j.lungcan.2008.10.006. Epub 2008 Nov 28.

PMID:
19046791
4.

Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes.

Donadio M, Ardine M, Berruti A, Beano A, Bottini A, Mistrangelo M, Bonardi S, Castiglione F, Generali D, Polimeni MA, Bretti S, Alabiso O, Bertetto O; Piemonte Oncology Network.

Oncology. 2005;69(5):408-13. Epub 2005 Nov 24.

PMID:
16319512
5.

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

Castagneto B, Zai S, Dongiovanni D, Muzio A, Bretti S, Numico G, Botta M, Sinaccio G.

Am J Clin Oncol. 2005 Jun;28(3):223-6. Erratum in: Am J Clin Oncol. 2005 Oct;28(5):444. Sinaccio, G [added].

PMID:
15923792
6.

Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature.

Filosso PL, Actis Dato GM, Ruffini E, Bretti S, Ozzello F, Mancuso M.

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1215-9. Review. No abstract available.

PMID:
15052231
7.

Multimodal management of stages III-IVa malignant thymoma.

Bretti S, Berruti A, Loddo C, Sperone P, Casadio C, Tessa M, Ardissone F, Gorzegno G, Sacco M, Manzin E, Borasio P, Sannazzari GL, Maggi G, Dogliotti L; Piemonte Oncology Network.

Lung Cancer. 2004 Apr;44(1):69-77.

PMID:
15013585
8.

Supportive care in patients with advanced non-small-cell lung cancer.

Di Maio M, Perrone F, Gallo C, Iaffaioli RV, Manzione L, Piantedosi FV, Cigolari S, Illiano A, Barbera S, Robbiati SF, Piazza E, Ianniello GP, Frontini L, Veltri E, Castiglione F, Rosetti F, De Maio E, Maione P, Gridelli C, Rossi A, Barletta E, Barzelloni ML, Signoriello G, Bilancia D, Dinota A, Rosati G, Germano D, Lamberti A, Pontillo V, Brancacio L, Crispino C, Esposito M, Battiloro C, Tufano G, Cioffi A, Guardasole V, Angelini V, Guidetti G, Barbera S, Renda F, Romano F, Volpintesta A, Robbiati SF, Sannicolò M, Filipazzi V, Esani G, Gambaro A, Ferrario S, Tinessa V, Caprio MG, Zonato S, Cabiddu M, Raina A, Veltri E, D'Aprile M, Pistillucci G, Porcile G, Ostellino O, Vinante O, Azzarello G, Gebbia V, Borsellino N, Testa A, Gasparini G, Morabito A, Gattuso D, Romito S, Carrozza F, Fava S, Calcagno A, Grimi E, Bertetto O, Ciuffreda L, Parello G, Maiorino L, Santoro A, Santoro M, Failla G, Aiello RA, Bearz A, Sorio R, Scalone S, Clerici M, Bollina R, Belloni P, Sacco C, Sibau A, Adamo V, Altavilla G, Scimone A, Spatafora M, Bellia V, Hopps MR, Monfardini S, Favaretto A, Stefani M, Corradini GM, Pavia G, Scagliotti G, Novello S, Selvaggi G, Tonato M, Darwish S, Michetti G, Belometti MO, Labianca R, Quadri A, De Marinis F, Migliorino MR, Martelli O, Colucci G, Galetta D, Giotta F, Isa L, Candido P, Rossi N, Calandriello A, Ferraù F, Malaponte E, Barni S, Cazzaniga M, Gebbia N, Valerio MR, Belli M, Colantuoni G, Capuano MA, Angiolillo M, Sollitto F, Ardizzoia A, Luporini G, Locatelli MC, Pari F, Aitini E, Pedicini T, Febbraro A, Zollo C, Di Costanzo F, Bartolucci R, Gasperoni S, Gaion F, Palazzolo G, Galligioni E, Caffo O, Cortesi E, D'Auria G, Curcio C, Vasta M, Bumma C, Celano A, Bretti S, Nettis G, Anselmo A, Mattioli R, Nisticò C, Aschelter A, Foa P.

Br J Cancer. 2003 Sep 15;89(6):1013-21.

9.

Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study.

Bretti S, Manzin E, Loddo C, Berruti A, Bombaci S, Vellani G, Celano A.

Anticancer Res. 2002 Sep-Oct;22(5):3039-43.

PMID:
12530039
10.

Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).

Parra HS, Tixi L, Latteri F, Bretti S, Alloisio M, Gravina A, Lionetto R, Bruzzi P, Dani C, Rosso R, Cosso M, Balzarini L, Santoro A, Ardizzoni A.

Cancer. 2001 Aug 1;92(3):650-6.

PMID:
11505411
11.

Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study.

Bretti S, Manzin E, Celano A, Ritorto G, Loddo C, Berruti A.

Oncol Rep. 2001 Mar-Apr;8(2):381-5.

PMID:
11182060
12.

Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas.

Comandone A, Bretti S, Bertetto O, Oliva C, Bergnolo P, Bumma C.

Anticancer Res. 2000 May-Jun;20(3B):2077-80.

PMID:
10928155
13.

Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer.

Clerici M, De Marinis F, Piazza E, Frontini L, Tucci E, Barni S, Bretti S, Luporini G, Intini C.

Tumori. 1998 Nov-Dec;84(6):669-72.

PMID:
10080674
14.

Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors.

Bretti S, Berruti A, Dogliotti L, Castagneto B, Bertulli R, Spadaro P, Toscano G, Astorre P, Verusio C, Lionetto R, Bruzzi P, Santoro A.

Tumori. 1998 Sep-Oct;84(5):558-61.

PMID:
9862516
15.

Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients.

Bretti S, Berruti A, Gorzegno G, La Ciura P, Pazè E, Celano A, Grecchi G, Perroni D, Bumma C, Dogliotti L.

Lung Cancer. 1996 Jun;14(2-3):353-60.

PMID:
8794416
16.

An open phase I study to assess the biological effects of a continuous intravenous infusion of Interleukin-3 followed by Granulocyte Macrophage-Colony Stimulating Factor.

Bretti S, Gilleece MH, Kamthan A, Fitzsimmons L, Hicks F, Rowlands M, Bishop P, Picardo AM, Dexter TM, Scarffe JH.

Eur J Cancer. 1996 Jun;32A(7):1171-8.

PMID:
8758249
17.

Stability of ifosfamide in solutions for multiday infusion by external pump.

Leone L, Comandone A, Oliva C, Bussi P, Goffredo F, Bretti S, Bumma C.

Anticancer Drugs. 1995 Aug;6(4):604-7.

PMID:
7579566
18.

Non small cell lung cancer treatment with vinorelbine monochemotherapy: a phase II study.

Clerici M, Bretti S, Celano A, Panvini D, Comandone A, Casadio C, Luporini G, Bumma C.

Anticancer Res. 1995 Mar-Apr;15(2):477-8.

PMID:
7763025
19.

Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.

Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, et al.

Clin Cancer Res. 1995 Feb;1(2):147-54.

20.

Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combination.

Lord BI, Testa NG, Bretti S, Chang J, Demuynck H, Coutinho L, de Campos E, Fitzsimmons L, Scarffe JH.

Int J Cancer. 1994 Nov 15;59(4):483-90.

PMID:
7960217
21.

Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.

Maggi G, Casadio C, Cianci R, Oliaro A, Molinatti M, Bretti S, Clerico M, Boidi-Trotti A, Rovea P.

J Cardiovasc Surg (Torino). 1994 Aug;35(4):341-6.

PMID:
7929550
22.

Cea and ca-19.9 as markers of colorectal neoplasms during chemotherapeutic treatment.

Comandone A, Bretti S, Aroasio E, Rapellino M, Bugiani M, Cotroneo F, Bumma C.

Oncol Rep. 1994 Jul;1(4):779-82.

PMID:
21607440
23.

Interleukin-3 in vivo: kinetic of response of target cells.

Aglietta M, Sanavio F, Stacchini A, Morelli S, Fubini L, Severino A, Pasquino P, Volta C, Bretti S, Tafuto S, et al.

Blood. 1993 Oct 1;82(7):2054-61.

24.

Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.

Comandone A, Bretti S, La Grotta G, Manzoni S, Bonardi G, Berardo R, Bumma C.

Anticancer Res. 1993 Sep-Oct;13(5C):1781-3.

PMID:
8267382
25.

[RAdio-chemo-surgical combined treatment of non-small cell lung carcinoma N2].

Rovea P, Sola B, Boidi Trotti A, Gabriele AM, Fracchia F, Casadio C, Bretti S.

Radiol Med. 1993 Jun;85(6):840-3. Italian.

PMID:
8393206
26.

Non small cell lung cancer treatment with carboplatin and vindesine: a phase II study.

Bretti S, Bonardi GM, Celano A, Comandone A, Casadio C, Marchisio U, Forconi G, Manzoni S, Bumma C.

Anticancer Res. 1992 Sep-Oct;12(5):1459-61.

PMID:
1332578
27.

[Metastasis to the penis from carcinoma of the rectum. A clinical case].

Comandone A, Bau G, Mo A, Bretti S, Alberghina A, Frigerio A, Bumma C.

Minerva Gastroenterol Dietol. 1992 Jan-Mar;38(1):49-52. Italian.

PMID:
1520754
28.

Expression of the Met/HGF receptor in normal and neoplastic human tissues.

Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM.

Oncogene. 1991 Nov;6(11):1997-2003.

PMID:
1719465
29.

[Treatment of N2-3 pulmonary carcinoma. Preoperative radio-chemotherapy].

Bertetto O, Boidi Trotti A, Bretti S, Casadio C, Clerico M, Gabriele AM, Giobbe R, Oliaro A, Seroni VT.

Minerva Med. 1991 Sep;82(9):539-43. Italian.

PMID:
1945001
30.

[Tyrosine-phosphorylated proteins in human breast carcinoma].

Bretti S, Cappa AP, Comoglio PM, Di Renzo MF.

J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):205-10. Italian.

PMID:
1709208
31.

Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell-binding site.

Bretti S, Neri P, Lozzi L, Rustici M, Comoglio P, Giancotti F, Tarone G.

Int J Cancer. 1989 Jan 15;43(1):102-6.

PMID:
2521334
32.

The monoclonal antibody-defined CAR-3 antigen is a serological marker associated with pancreatic carcinoma.

Prat M, Medico E, Piantino P, Bretti S, Rossini FP, Comoglio PM.

Int J Biol Markers. 1988 Jan-Mar;3(1):29-35.

PMID:
2977786
33.

Monoclonal antibodies against murine IFN-gamma abrogate in vivo tumor immunity against RSV-induced murine sarcomas.

Prat M, Bretti S, Amedeo M, Landolfo S, Comoglio PM.

J Immunol. 1987 Jun 15;138(12):4530-3.

PMID:
3035023
34.
35.

Supplemental Content

Loading ...
Support Center